Department of Medicine, Hospital for Special Surgery, New York, United States.
Department of Medicine, Weill Cornell Medicine, New York, United States.
Thromb Haemost. 2017 Nov;117(11):2176-2185. doi: 10.1160/TH17-06-0395. Epub 2017 Nov 30.
Clinical decision rules (CDRs) for pulmonary embolism (PE) have been validated in outpatients, but their performance in hospitalized patients is not well characterized. The goal of this systematic literature review was to assess the performance of CDRs for PE in hospitalized patients. We performed a structured literature search using Medline, EMBASE and the Cochrane library for articles published on or before January 18, 2017. Two authors reviewed all titles, abstracts and full texts. We selected prospective studies of symptomatic hospitalized patients in which a CDR was used to estimate the likelihood of PE. The diagnosis of PE had to be confirmed using an accepted reference standard. Data on hospitalized patients were solicited from authors of studies in mixed populations of outpatients and hospitalized patients. Study characteristics, PE prevalence and CDR performance were extracted. The methodological quality of the studies was assessed using the QUADAS instrument. Twelve studies encompassing 3,942 hospitalized patients were included. Studies varied in methodology (randomized controlled trials and observational studies) and reference standards used. The pooled sensitivity of the modified Wells rule (cut-off ≤ 4) in hospitalized patients was 72.1% (95% confidence interval [CI], 63.7-79.2) and the pooled specificity was 62.2% (95% CI, 52.6-70.9). The modified Wells rule (cut-off ≤ 4) plus D-dimer testing had a pooled sensitivity 99.7% (95% CI, 96.7-100) and pooled specificity 10.8% (95% CI, 6.7-16.9). The efficiency (proportion of patients stratified into the 'PE unlikely' group) was 8.4% (95% CI, 4.1-16.5), and the failure rate (proportion of low likelihood patients who were diagnosed with PE during follow-up) was 0.1% (95% CI, 0-5.3). In symptomatic hospitalized patients, use of the Wells rule plus D-dimer to rule out PE is safe, but allows very few patients to forgo imaging.
临床决策规则(CDR)已在门诊患者中得到验证,但它们在住院患者中的表现尚未得到很好的描述。本系统文献综述的目的是评估 CDR 在住院患者中诊断 PE 的性能。我们使用 Medline、EMBASE 和 Cochrane 图书馆对 2017 年 1 月 18 日之前发表的文章进行了结构化文献检索。两名作者审查了所有标题、摘要和全文。我们选择了使用 CDR 来评估 PE 可能性的症状性住院患者的前瞻性研究。PE 的诊断必须使用公认的参考标准来确认。来自门诊和住院患者混合人群研究的作者处收集了住院患者的数据。提取了研究特征、PE 患病率和 CDR 性能。使用 QUADAS 工具评估了研究的方法学质量。共纳入了 12 项研究,涵盖了 3942 例住院患者。研究方法(随机对照试验和观察性研究)和参考标准各不相同。在住院患者中,改良 Wells 规则(截断值≤4)的合并敏感性为 72.1%(95%置信区间,63.7-79.2),合并特异性为 62.2%(95%置信区间,52.6-70.9)。改良 Wells 规则(截断值≤4)加 D-二聚体检测的合并敏感性为 99.7%(95%置信区间,96.7-100),合并特异性为 10.8%(95%置信区间,6.7-16.9)。效率(分为“PE 不太可能”组的患者比例)为 8.4%(95%置信区间,4.1-16.5),失败率(低度可能性患者在随访期间被诊断为 PE 的比例)为 0.1%(95%置信区间,0-5.3)。在有症状的住院患者中,使用 Wells 规则加 D-二聚体排除 PE 是安全的,但允许很少的患者避免影像学检查。